Broad Blockade Antibody Responses in Human Volunteers after Immunization with a Multivalent Norovirus VLP Candidate Vaccine: Immunological Analyses from a Phase I Clinical Trial

2013

2011, Updated norovirus outbreak management and disease prevention guidelines, MMWR Recomm Rep, 60, 1

TK Trivedi, 2013, Clinical characteristics of norovirus-associated deaths: a systematic literature review, Am J Infect Control, 41, 654, 10.1016/j.ajic.2012.08.002

K Bok, 2012, Norovirus gastroenteritis in immunocompromised patients, N Engl J Med, 367, 2126, 10.1056/NEJMra1207742

TK Trivedi, 2012, Hospitalizations and mortality associated with norovirus outbreaks in nursing homes, 2009–2010, JAMA, 308, 1668, 10.1001/jama.2012.14023

AM Hutson, 2004, Norovirus disease: changing epidemiology and host susceptibility factors, Trends Microbiol, 12, 279, 10.1016/j.tim.2004.04.005

MK Estes, 2006, Noroviruses everywhere: has something changed?, Curr Opin Infect Dis, 19, 467, 10.1097/01.qco.0000244053.69253.3d

M Koopmans, 2000, Molecular epidemiology of human enteric caliciviruses in The Netherlands, J Infect Dis, 181, S262, 10.1086/315573

2007, Norovirus activity—United States, 2006–2007, MMWR Morb Mortal Wekly Rep, 56, 842

M Okada, 2006, Genetic analysis of noroviruses associated with fatalities in healthcare facilities, Arch Virol, 151, 1635, 10.1007/s00705-006-0739-6

JP Harris, 2008, Deaths from norovirus among the elderly, England and Wales, Emerg Infect Dis, 14, 1546, 10.3201/eid1410.080188

R Schorn, 2010, Chronic norovirus infection after kidney transplantation: molecular evidence for immune-driven viral evolution, Clin Infect Dis, 51, 307, 10.1086/653939

AJ Hall, 2012, Epidemiology of foodborne norovirus outbreaks, United States, 2001–2008, Emerg Infect Dis, 18, 1566, 10.3201/eid1810.120833

A Kroneman, 2008, Data quality of 5 years of central norovirus outbreak reporting in the European Network for food-borne viruses, J Public Health (Oxf), 30, 82, 10.1093/pubmed/fdm080

DP Zheng, 2006, Norovirus classification and proposed strain nomenclature, Virology, 346, 312, 10.1016/j.virol.2005.11.015

KY Green, 1993, Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations, J Clin Microbiol, 31, 2185, 10.1128/JCM.31.8.2185-2191.1993

BV Prasad, 1999, X-ray crystallographic structure of the Norwalk virus capsid, Science, 286, 287, 10.1126/science.286.5438.287

L Lindesmith, 2003, Human susceptibility and resistance to Norwalk virus infection, Nat Med, 9, 548, 10.1038/nm860

LC Lindesmith, 2008, Mechanisms of GII.4 norovirus persistence in human populations, PLoS Med, 5, e0050031, 10.1371/journal.pmed.0050031

LC Lindesmith, 2013, Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes, J Virol, 87, 2803, 10.1128/JVI.03106-12

K Bok, 2011, Chimpanzees as an animal model for human norovirus infection and vaccine development, Proc Natl Acad Sci U S A, 108, 325, 10.1073/pnas.1014577107

A Reeck, 2010, Serological correlate of protection against norovirus-induced gastroenteritis, J Infect Dis, 202, 1212, 10.1086/656364

RL Atmar, 2011, Norovirus vaccine against experimental human Norwalk Virus illness, N Engl J Med, 365, 2178, 10.1056/NEJMoa1101245

JJ Siebenga, 2007, Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006, J Virol, 81, 9932, 10.1128/JVI.00674-07

LC Lindesmith, 2012, Immunogenetic mechanisms driving norovirus GII.4 antigenic variation, PLoS Pathog, 8, e1002705, 10.1371/journal.ppat.1002705

LC Lindesmith, 2011, Norovirus GII.4 strain antigenic variation, J Virol, 85, 231, 10.1128/JVI.01364-10

K Debbink, 2012, Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity, J Virol, 86, 1214, 10.1128/JVI.06189-11

JL Cannon, 2009, Herd immunity to GII.4 noroviruses is supported by outbreak patient sera, J Virol, 83, 5363, 10.1128/JVI.02518-08

K Debbink, 2013, Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity, J Infect Dis, 208, 1877, 10.1093/infdis/jit370

EF Donaldson, 2008, Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations, Immunol Rev, 225, 190, 10.1111/j.1600-065X.2008.00680.x

LC Lindesmith, 2012, Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002, J Virol, 86, 873, 10.1128/JVI.06200-11

LC Lindesmith, 2014, Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope, J Virol, 88, 8826, 10.1128/JVI.01192-14

JS Eden, 2013, Recombination within the pandemic norovirus GII.4 lineage, J Virol, 87, 6270, 10.1128/JVI.03464-12

RA Bull, 2010, Rapid evolution of pandemic noroviruses of the GII.4 lineage, PLoS Pathog, 6, e1000831, 10.1371/journal.ppat.1000831

JJ Siebenga, 2010, Phylodynamic reconstruction reveals norovirus GII.4 epidemic expansions and their molecular determinants, PLoS Pathog, 6, e1000884, 10.1371/journal.ppat.1000884

C Richardson, 2013, Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis, Expert Rev Vaccines, 12, 155, 10.1586/erv.12.145

JJ Treanor, 2014, A novel intramuscular bivalent norovirus virus-like particle vaccine candidate-reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults, J Infect Dis, 210, 1763, 10.1093/infdis/jiu337

EF Donaldson, 2010, Viral shape-shifting: norovirus evasion of the human immune system, Nat Rev Microbiol, 8, 231, 10.1038/nrmicro2296

J Nordgren, 2010, Norovirus gastroenteritis outbreak with a secretor-independent susceptibility pattern, Sweden, Emerg Infect Dis, 16, 81, 10.3201/eid1601.090633

R Frenck, 2012, Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humans, J Infect Dis, 206, 1386, 10.1093/infdis/jis514

L Lindesmith, 2005, Cellular and humoral immunity following Snow Mountain virus challenge, J Virol, 79, 2900, 10.1128/JVI.79.5.2900-2909.2005

Bernstein DI, Atmar RL, Lyon GM, Treanor JJ, Chen WH, et al. (2014) Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults. J Infect Dis. E-pub ahead of print. <comment>doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/infdis/jiu497" xlink:type="simple">10.1093/infdis/jiu497</ext-link></comment>

J Swanstrom, 2014, Characterization of blockade antibody responses in GII.2.1976 Snow Mountain virus-infected subjects, J Virol, 88, 829, 10.1128/JVI.02793-13

AD LoBue, 2006, Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains, Vaccine, 24, 5220, 10.1016/j.vaccine.2006.03.080

K Debbink, 2014, Within-host evolution results in antigenically distinct GII.4 noroviruses, J Virol, 88, 7244, 10.1128/JVI.00203-14

Z Cai, 2010, A computational framework for influenza antigenic cartography, PLoS Comput Biol, 6, e1000949, 10.1371/journal.pcbi.1000949

F Wang, 2013, Somatic hypermutation maintains antibody thermodynamic stability during affinity maturation, Proc Natl Acad Sci U S A, 110, 4261, 10.1073/pnas.1301810110

D Hoffmann, 2012, Norovirus GII.4 and GII.7 capsid sequences undergo positive selection in chronically infected patients, Infect Genet Evol, 12, 461, 10.1016/j.meegid.2012.01.020

JL Barnett, 2012, AntigenMap 3D: an online antigenic cartography resource, Bioinformatics, 28, 1292, 10.1093/bioinformatics/bts105

K Debbink, 2012, Norovirus immunity and the great escape, PLoS Pathog, 8, e1002921, 10.1371/journal.ppat.1002921

LC Lindesmith, 2010, Heterotypic humoral and cellular immune responses following Norwalk virus infection, J Virol, 84, 1800, 10.1128/JVI.02179-09

AG Schmidt, 2013, Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody, Proc Natl Acad Sci U S A, 110, 264, 10.1073/pnas.1218256109

GM Li, 2012, Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells, Proc Natl Acad Sci U S A, 109, 9047, 10.1073/pnas.1118979109

M Kobayashi, 2012, Immunogenicity and reactogenicity of a monovalent inactivated 2009 influenza A vaccine in adolescents: with special reference to pre-existing antibody, J Pediatr, 160, 632, 10.1016/j.jpeds.2011.09.055

MC Knuchel, 2013, Relevance of a pre-existing measles immunity prior immunization with a recombinant measles virus vector, Hum Vaccin Immunother, 9, 599, 10.4161/hv.23241

XF Liang, 2010, Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial, Lancet, 375, 56, 10.1016/S0140-6736(09)62003-1

FC Zhu, 2009, A novel influenza A (H1N1) vaccine in various age groups, N Engl J Med, 361, 2414, 10.1056/NEJMoa0908535

J Wrammert, 2008, Rapid cloning of high-affinity human monoclonal antibodies against influenza virus, Nature, 453, 667, 10.1038/nature06890

JR Mora, 2008, Homing imprinting and immunomodulation in the gut: role of dendritic cells and retinoids, Inflamm Bowel Dis, 14, 275, 10.1002/ibd.20280

NA Kuklin, 2001, Protective intestinal anti-rotavirus B cell immunity is dependent on alpha 4 beta 7 integrin expression but does not require IgA antibody production, J Immunol, 166, 1894, 10.4049/jimmunol.166.3.1894

DJ Smith, 2004, Mapping the antigenic and genetic evolution of influenza virus, Science, 305, 371, 10.1126/science.1097211

SW Huang, 2009, Reemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008, J Clin Microbiol, 47, 3653, 10.1128/JCM.00630-09

K Debbink, 2014, Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses, J Virol, 88, 7256, 10.1128/JVI.00785-14

D Corti, 2010, Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine, J Clin Invest, 120, 1663, 10.1172/JCI41902

J Lessler, 2012, Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China, PLoS Pathog, 8, e1002802, 10.1371/journal.ppat.1002802